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OnSummary
Equine sarcoids are benign ﬁbroblastic skin tumours that are recognized throughout the world. Infection with
bovine papillomavirus (BPV) types 1 and 2 has been implicated as a major factor in disease development; how-
ever, the cellular mechanisms underlying ﬁbroblast transformation remain poorly deﬁned. The present study
further characterizes aspects of the association with BPV in 15 equine sarcoids. BPVDNAwas demonstrated in
12/15 tumours collected from different areas of Italy. Nine of these 12 tumours expressed the BPV oncoproteins
E5 and E7, but these oncoproteins were not expressed by normal equine cells. The BPV E5 protein is known to
bind to the platelet-derived growth factor-b receptor (PDGF-bR) and this molecule was expressed by 11 of the
12 sarcoids in which E5 was demonstrated. These ﬁndings add further weight to the theory that BPV and the
PDGF-bR may have a role in the pathogenesis of this disease.
 2008 Published by Elsevier Ltd.Keywords: bovine papillomavirus; horse; platelet-derived growth factor-b receptor; sarcoidIntroduction
Sarcoids are benign tumours of ﬁbroblastic origin
affecting the skin of horses, mules and donkeys and
are considered to be the most common equine cutane-
ous neoplasm. The tumours most frequently arise
from the skin of the head, ventral abdomen, legs
and the paragenital region (Ragland et al., 1970).
Sarcoids are locally invasive and often occur at sites
of previous injury or scarring.
Bovine papillomavirus (BPV) is considered to be
the aetiological agent of this tumour (Borzacchiello,
2008). Both BPV-1 and -2 have been detected in sar-
coids with BPV-1 being predominant (Lancaster
et al., 1979; Amtmann et al., 1980; Chambers et al.,
2003). Equine sarcoid is an important tumour since
it provides the only known example of natural cross-
species infection by a papillomavirus. Moreover,
while BPV infection in cattle produces benign lesionsondence to: G. Borzacchiello. (e-mail: borzacch@unina.it).
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the horse is distinctly different as sarcoids are non-
permissive for virus production, locally aggressive
and rarely show regression (Borzacchiello, 2007).
Candidate molecules involved in BPV oncogenesis
have been characterized. The BPV-1 E5 oncogene
encodes a 44 amino acid protein that is considered
to be the major BPV oncoprotein (Schiller et al.,
1986; Schlegel et al., 1986). E5 is a type II transmem-
brane protein that is expressed in the deep layers of
infected epithelia (Burnett et al., 1992; Anderson
et al., 1997; Venuti and Campo, 2002) and is largely
localized to the membranes of the endoplasmic retic-
ulum (ER) and Golgi apparatus (GA) of these cells
(Burkhardt et al., 1989; Pennie et al., 1993). BPV
E5 is expressed in the cytoplasm of both basal and
suprabasal transformed epithelial cells (Bohl et al.,
2001; Araibi et al., 2004) with a typical juxtanuclear
pattern due to its localization in the GA (Borzacchiello
et al., 2003).
The mechanism underlying BPV carcinogenesis
is thought to relate to the binding (both in vitro and 2008 Published by Elsevier Ltd.
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ARTICLE IN PRESSin vivo) of the E5 oncoprotein to the platelet-derived
growth factor-b receptor (PDGF-bR) (DiMaio
et al., 2000; DiMaio and Mattoon, 2001; Borzac-
chiello et al., 2006). This mechanism has been largely
investigated in vitro and in naturally occurring bovine
bladder cancer. However, in the latter situation, syn-
ergism between the virus and carcinogenic principles
from bracken fern is required for full transformation
(Campo et al., 1992; Borzacchiello et al., 2003).
The BPV-1 E7 gene encodes a 127 amino acid zinc-
binding protein that co-operates with E5 and E6 in
inducing cell transformation. In natural infection,
BPV-1 E7 expression occurs in the cytoplasm and nu-
cleoli of cells of the basal and lower spinous layers of
squamous epithelium. Once E7 is co-expressed with
E5 and E6, the transformation capacity of the virus
increases many fold (Bohl et al., 2001). Such co-
expression may also occur in bovine tumours of mes-
enchymal origin (Borzacchiello et al., 2007). Mutants
lacking the E7 open reading frame are still able to in-
duce transformation but at a lower efﬁciency, and
produce transformants with altered characteristics
(Sarver et al., 1984).
The mechanisms described above have been
largely investigated in bovine tumours and there are
no studies published to date concerning the molecular
mechanisms underlying BPV transformation in
equine sarcoids. The aim of the present study was
therefore to determine whether the mechanisms de-
scribed in bovine carcinogenesis might also occur in
equine sarcoid by examining the expression of key on-
cogenic molecules in the equine tumour.Materials and methods
Tumour Samples
Examples of equine sarcoid (n¼ 15) were derived
from the archives of the Department of Pathology
and Animal Health, Naples University, and the
Department of Comparative Biomedical Sciences,
University of Teramo. Formalin-ﬁxed tissue embed-
ded in parafﬁn wax was available from each case. Sec-
tions taken from these blocks and stained by
haematoxylin and eosin (HE) were re-evaluated by
two observers (GB and VR) and the original diagno-
sis of sarcoid was conﬁrmed. The 15 samples were de-
rived from 13 different animals. The breeds of these
animals included: Arabian thoroughbred (n¼ 3),
Maremmano (n¼ 1), draft horse (n¼ 6), thorough-
bred (n¼ 3), standard bred (n¼ 2), and one donkey
and one mule. Seven were stallions, ﬁve were geldings
and three were mares. The median age of the animals
was 6 years old.Please cite this article in press as: Borzacchiello G et al., Expression of Platel
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DNA was extracted from the tissue embedded in par-
afﬁn wax with the DNeasy Tissue Kit (Quiagen,
Milan, Italy) according to the manufacturer’s proto-
col. Samples were lysed using proteinase K. Lysates
were loaded onto DNeasy spin columns and, after
two washes, pure DNA was eluted in low salt buffer.
Ampliﬁcation of the E5 open reading frame (ORF)
was carried out by polymerase chain reaction (PCR)
using a BPV-1 and -2 consensus primer pair, BPVE5F
(TTGCTGCAATGCAACTGCTG corresponding
to BPV nucleotides 3915e3934) and BPVE5R (TCA-
TAGGCACTGGCACGTT corresponding to BPV
nucleotides 4208e4225) amplifying a fragment of
311 bp from nucleotide 3915 to 4225. To evaluate
the adequacy of the DNA, a control PCR for equine
glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) sequence was performed using the primers
published by Yuan et al. (2008).
Aliquots (200e300 ng) of puriﬁed DNA were am-
pliﬁed in a 50 ml reaction system containing 1 Pfx
ampliﬁcation buffer, 0.3 mM dNTP mixture, 1 mM
MgSO4, 0.3 mM primer mixes and 1 unit platinum
Pfx DNA polymerase (Invitrogen, Carlsbad, CA,
USA). Cycling conditions were as follows: denatur-
ation for 2 min at 94C, followed by 28 cycles of
PCR ampliﬁcation comprising denaturation at 94C
for 15 s, annealing at 50C for 30 s and extension at
68C for 50 s, followed by a ﬁnal extension at 68C
for 7 min. Detection of the ampliﬁed products was
carried out by electrophoresis in an ethidium bro-
mide-stained agarose gel. Each experiment included
a blank sample consisting of reaction mixture without
DNA. PCR products were puriﬁed by Switch-
Charge beads (Invitrogen) and sequenced using
the Applied Biosystems (Foster City, CA, USA) Big
Dye terminator cycle sequencing reagents and se-
quences were obtained by the use of an ABI 3100 au-
tomated sequencer. Sequence analysis was performed
with Basic Local Alignment Search Tool (BLAST).
Immunohistochemistry
Sections were prepared from the 12 sarcoids in which
BPV DNA had been detected. Brieﬂy, the sections
were de-waxed and then endogenous peroxidase ac-
tivity was blocked by incubation in H2O2 0.3% in
methanol for 20 min. Antigen retrieval was per-
formed by pretreating with microwave heating (twice
for 5 min each at 750 W) in citrate buffer pH 6.0. The
primary antibodies were applied overnight at 4C
in a humid chamber. The polyclonal rabbit anti-E7
(a gift from Professor P. Howley, Harvard Medical
School, Boston, USA) was applied at a dilution of 1
in 2000; the polyclonal rabbit anti-PDGF-b receptoret-derived Growth Factor-b Receptor and Bovine Papillomavirus E5 and
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ARTICLE IN PRESS(a gift from Professor DiMaio, Yale Medical School,
New Haven, USA) was applied at a dilution of 1 in
1000; and monoclonal antibody against the prolifera-
tion marker Ki 67 (Clone MIB-1, Dako, Glostrup,
Denmark) was applied at a dilution of 1 in 100.
Following incubation with primary antisera, the
slides were washed three times with phosphate-
buffered saline (PBS), then incubated for 30 min
with the appropriate biotinylated secondary antibody
(labelled streptavidinebiotin [LSAB] Kit; Dako).
Sections were washed three times with PBS and
then incubated with streptavidin-conjugated to
horseradish peroxidase (LSAB Kit; Dako). Colour
development was obtained by treatment with diami-
nobenzidine (Dako) for 5e20 min. Sections were
counterstained with Mayer’s haematoxylin. Negative
controls included omission of the primary antiserum
or replacement of these by appropriate normal sera.
A sample of normal equine skin was also included as
a further control.
The scoring of the immunoreactivity was deter-
mined in blinded fashion by two observers (GB and
SM). The intensity of labelling in each specimen
was scored as follows: () absent or very weak label-
ling, (+) weak, (++) moderate, or (+++) strong
labelling. Proliferation index (PI) was derived from
the Ki67 labelled sections by counting 1000 cells
over 10 ﬁelds (examined with the 40 objective).Immunoﬂuorescence and Confocal Laser Scanning Microscopy
Brieﬂy, sections from the parafﬁn wax embedded tis-
sue were de-waxed, rehydrated and heated in amicro-
wave oven in citrate buffer (as above) to allow antigen
unmasking. Slides were then incubated with poly-
clonal sheep anti-E5 antiserum (a gift from Professor
M.S. Campo, University of Glasgow, Scotland, UK)
at a dilution of 1 in 50, and thereafter with secondary
sheep antibody conjugated to ﬂuorescein isothiocya-
nate (FITC; Chemicon, Billerica,MA,USA). For ob-
servation and photography, a confocal laser scanning
microscope LSM-510 (Zeiss, Go¨ttingen, Germany)
was used as previously reported (Borzacchiello et al.,
2003).SDS PAGE and Western Blotting
Two fresh unﬁxed tumour samples and one sample of
normal skin were available for molecular analysis.
These were snap frozen in liquid nitrogen and
homogenized in 7.5 ml JS buffer (5 ml 1 M Hepes
pH 7.5, 3 ml 5 M NaCl, 1 ml glycerol, 10 ml 10%
Triton, 0.15 ml 1 M MgCl2, 5 ml 0.1 M EGTA)
with the addition of 2 ml 0.1 M sodium pyrophos-
phate, 0.2 ml aprotinin 5 mg/ml, 0.2 ml 0.1 MPlease cite this article in press as: Borzacchiello G et al., Expression of Platel
E7 Oncoproteins in Equine Sarcoid, Journal of Comparative Pathology (20phenylmethylsulfonyl ﬂuoride (PMSF), 0.2 ml
500 mM sodium orthovanadate (Na2VO3) and
0.25 ml 2 M NaF. Protein concentration was deter-
mined by use of a protein assay kit (Bio-Rad, Hercu-
les, CA, USA). The protein extracts were loaded onto
a 7.5% polyacrylamide gel and electrophoresed. The
proteins were transferred from the gel onto polyviny-
lidene ﬂuoride (PVDF) membranes by western blot-
ting.
The membranes were blocked with 5% non-fat
milk powder in Tris-buffered saline (TBS) at room
temperature, washed with TBS-0.1% Tween-20 and
incubated with polyclonal antibody against PDGF-
bRat a 1 in 250 dilution overnight at 4C. After wash-
ing, peroxidase-conjugated anti-rabbit IgG (Santa
Cruz Biotechnology Inc., Santa Cruz, CA, USA) at
a dilution of 1 in 1000 was applied to the blots for
2 h. Following further washing, bound antibody was
visualized on enhanced chemiluminescence (ECL)
ﬁlm (Amersham Pharmacia Biotech, Uppsala, Swe-
den). The blots were stripped and re-probed with
anti-b actin antibody (Calbiochem, Darmstadt, Ger-
many) at a dilution of 1 in 5000 to conﬁrm equal load-
ing of proteins in each lane.Results
Detection of Bovine Papillomavirus DNA
DNA of PCR-quality was recovered from all of the
samples. A fragment of the expected size was ampli-
ﬁed from 12 of the 15 tumour samples (80%)
(Fig. 1). In order to determine the papillomavirus
type the PCR amplicons were sequenced. Two of
the 12 positive samples (numbers T3 and T7) were
shown to contain BPV-2 DNA (17%), whereas the re-
maining 10 tumours contained BPV-1 DNA (83%).
No association was found between the presence of
BPV type-1 or -2 DNA and a particular type of
tumour (data not shown).Expression of E5, E7 and PDGF-bR
E5 protein was identiﬁed in nine of the 12 BPV-posi-
tive tumours (75%). Almost all neoplastic cells from
BPV DNA-positive tumour samples displayed cyto-
plasmic E5 immunoreactivity. E5 was found mostly
within the cytoplasm of neoplastic ﬁbroblasts and
particularly in a juxtanuclear location (Fig. 2). Nor-
mal ﬁbroblasts in an area adjacent to the tumour
did not express E5 (data not shown).
E7 expression was detected in nine of the 12
BPV-positive tumours (75%). Almost all neoplastic
ﬁbroblasts were positively labelled. The labelling
was cytoplasmic, but in some samples intranuclear la-
belling was also recorded. The intensity of labellinget-derived Growth Factor-b Receptor and Bovine Papillomavirus E5 and
07), doi:10.1016/j.jcpa.2008.07.006
Fig. 1. PCR ampliﬁcation of BPV DNA from 12 equine sarcoids. The arrow indicates the position of the 311 bp BPV PCR product. The
tumour samples are numbered T1eT12, which corresponds with the numbering in Table 1.MW,molecular mass marker type VI
(Roche Diagnostics); B, negative control with no DNA added. Ampliﬁcation of GAPDH from all the samples is shown in the cor-
responding gel below.
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strong (n¼ 1) (Fig. 3; Table 1). Normal ﬁbroblasts
and other mesenchymal cells did not express E7.
Eleven of the 12 samples expressing E5 also
expressed the PDGF-bR (91%). The positive label-
ling ranged from very weak (n¼ 1) to moderate
(n¼ 4) or strong (n¼ 6) (Table 1). The receptor
was also expressed by normal blood vessels as previ-
ously described (Borzacchiello et al., 2006) (Fig. 4A).
To further conﬁrm receptor expression a western
blot analysis was performed on two tumour samples
and one normal equine skin. The antibody demon-
strated a band of the expected molecular weight in
the neoplastic tissues (Fig. 4B).Fig. 2. E5 expression in equine sarcoids. Most neoplastic ﬁbro-
blasts show cytoplasmic immunoreactivity with typical
juxtanuclear labelling (arrowed). IF. 240.
Please cite this article in press as: Borzacchiello G et al., Expression of Platel
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Ki67 immunoreactivity was detected in all 12 BPV
DNA-positive tumour samples. The percentage of la-
belled cells ranged from 1.5 to 12.7, with a mean PI of
5.7%. PI in normal equine skin was recorded as 0.Discussion
The results of the present study clearly show an asso-
ciation between BPV and equine sarcoid. Both BPV
DNA and the two transforming oncoproteins E5
and E7 were expressed by the majority of tumours ex-
amined. To our knowledge, this is the ﬁrst demonstra-
tion of the presence of BPV DNA in sarcoids collected
from animals living in different areas of Italy. The
80% positivity for BPV DNA in this series is similar
to the reported incidence of detection of viral DNA
in these tumours in other geographical areas, which
ranges from 73% to 100% (Otten et al., 1993; Bloch
et al., 1994; Carr et al., 2001a,b; Martens et al.,Fig. 3. E7 expression in equine sarcoids. Most neoplastic ﬁbro-
blasts show cytoplasmic immunoreactivity. IHC. 240.
et-derived Growth Factor-b Receptor and Bovine Papillomavirus E5 and
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Table 1
Expression of BPV-1 or -2 DNA, oncoproteins E5 and E7,
and PDGF-bR in equine sarcoid
Tumour number Viral DNA E5 E7 PDGF-b receptor
T1 BPV-1 + ++ ++
T2 BPV-1 + +++ ++
T3 BPV-2 + ++ +
T4 BPV-1 + ++ +++
T5 BPV-1 + ++ +++
T6 BPV-1 0 + +++
T7 BPV-2 + + +++
T8 BPV-1 + 0 +++
T9 BPV-1 0 + ++
T10 BPV-1 + + +++
T11 BPV-1 + 0 0
T12 BPV-1 0 0 ++
T13 None n/a n/a n/a
T14 None n/a n/a n/a
T15 None n/a n/a n/a
Expression of E5 was determined by immunoﬂuorescence and scored
as present (+) or absent (). The scoring of the intensity of immuno-
labelling for E7 and PDGF-bR was: (), absent or very weak signal;
(+), weak signal; (++), moderate signal; (+++), strong signal.
Tumours T13eT15 did not contain BPV DNA and were not assessed
(n/a) for the remaining parameters.
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tion rate may in part reﬂect differences in tumour ﬁx-
ation, as in our experience a prolonged period of
storage in formalin reduces the likelihood of isolation
of BPV DNA (data not shown). Both BPV-1 and -2Fig. 4. PDGF-b receptor expression in equine sarcoids. (A)
PDGF-bR is expressed within the cytoplasm of neoplastic
ﬁbroblasts. IHC. 240. (B) Homogenized samples from
two equine sarcoids (T3 and T7) and one sample of
normal skin (N) were analysed by western blotting with
rabbit anti-PDGF-bR. The blots were then stripped and
re-probed withmouse anti-b actin antibody. The receptor
is expressed in sarcoids and not in the normal skin.
Please cite this article in press as: Borzacchiello G et al., Expression of Platel
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predominant type. However, there was no association
between the virus type and the histological type of the
tumour or expression of BPV oncoproteins or PDGF-
bR. This observation suggests that the formation of
tumours of differing histological appearance is related
to factors other than the type of BPVwithin the lesion.
E5 and E7 are the transforming proteins of the
BPV. The amino acid sequence of E5 is identical in
BPV-1 and -2 (Schlegel et al., 1986), so that a single
polyclonal antiserum may be used to evaluate tu-
mours containing both virus subtypes. This was con-
ﬁrmed by the results of our study, where E5 was
expressed in sarcoids containing BPV-1 or -2 DNA
without apparent difference. The expression of E5 in
these tumours suggests that this oncogene has a role
in ﬁbroblastic transformation. BPVE5 is known to in-
duce cell transformation of cultured rodent ﬁbroblasts
and keratinocytes by binding to and activating the
PDGF-bR, a type I transmembrane receptor tyrosine
kinase. By contrast, E5 does not directly activate ei-
ther the a subunit of the PDGF receptor or the epithe-
lial growth factor (EGF) receptor (Leptak et al., 1991;
Petti and DiMaio, 1994; DiMaio et al., 2000). Each
E5 dimer binds to two molecules of the PDGF-bR,
forming a stable complex with these receptors and re-
sulting in their activation. This activation involves ty-
rosine phosphorylation of each receptor molecule in
the complex, and activation of the cellular SH2 do-
main-containing signalling proteins (Lai et al., 1998,
2000; DiMaio and Mattoon, 2001). This mechanism
occurs in vitro as well as in naturally occurring bovine
bladder epithelial cancer (Borzacchiello et al., 2006).
The present study has shown that the PDGF-b recep-
tor is also expressed in E5-positive equine sarcoids,
suggesting that similar molecular mechanisms may
be at play in the development of this tumour.
The BPV E7 oncoprotein is not thought to be di-
rectly involved in transformation, but to act by en-
hancing the transforming activity of the E5 and E6
oncoproteins (Bohl et al., 2001). However, it has re-
cently been shown that BPV E7 binding to p-600
can lead to, at least in part, cellular transformation
(Huh et al., 2005). We found E7 expression in the cy-
toplasm of ﬁbroblasts in almost all sarcoids and E5
and E7 were co-expressed in some tumour samples,
suggesting that these molecules may co-operate in tu-
mour formation.
The PI of the equine sarcoids examined in this
study was low. This ﬁnding is in accordance with
other studies where the observed PI ranged from
0% to 11% (Martens et al., 2000; Nixon et al.,
2005). This low rate of proliferation is reﬂected in
the clinical observation that sarcoids are slow growing
tumours.et-derived Growth Factor-b Receptor and Bovine Papillomavirus E5 and
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equine sarcoids harbouring BPV DNA expresses the
viral oncoproteins E5 and E7 together with the
PDGF-bR.Ongoing studies are investigating possible
receptor activation and downstream signalling lead-
ing to cellular transformation in order to gain further
insight into the pathogenesis of formation of this neo-
plasm.
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